InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,307.01
(
-0.27%
)
US TECH 100
18,228.40
(
0.00%
)
Dow Jones
39,671.04
(
-0.51%
)
Brent Oil
81.66
(
0.15%
)
Bitcoin
69,765.51
(
0.96%
)
Post# of 251903
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 253
Posts 17930
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: None

Tuesday, 05/08/2007 3:04:19 AM

Tuesday, May 08, 2007 3:04:19 AM

Post# of 251903
BIOLEX and GENMAB:

http://www.biolex.com/pdfs/Genmab%20Agreement%20Release%20-%20May%207,%202007.pdf

This may be an agreement for development of antibody fragments.
In any event, Genmab joins MEDX, Centocor, MEDI to evaluate the
LEX technology of Biolex, predicated on production of proteins
in duckweed.

http://www.biolex.com/

http://www.genmab.com/ScienceAndResearch/UniBodyTechnology.aspx


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up